Amphotericin B Associated Pulmonary Complications in Chronic Granulomatous Disease Patients

Pediatr Blood Cancer. 2016 Oct;63(10):1871-2. doi: 10.1002/pbc.26080. Epub 2016 Jul 8.

Authors

Juan Carlos Bustamante-Ogando¹, Francisco Rivas-Larrauri², Lizbeth Blancas-Galicia¹, Francisco Otero-Mendoza³, Marco Antonio Yamazaki-Nakashimada²

Affiliations

¹ Immunodeficiencies Research Unit, National Institute of Pediatrics, Mexico City, Mexico.
² Clinical Immunology Department, National Institute of Pediatrics, Mexico City, Mexico.
³ Clinical Infectious Diseases Department, National Institute of Pediatrics, Mexico City, Mexico.

PMID: 27391767
DOI: 10.1002/pbc.26080

No abstract available

Publication types

Letter

MeSH terms

Amphotericin B / adverse effects*
Amphotericin B / therapeutic use
Antifungal Agents / adverse effects
Antifungal Agents / therapeutic use
Granulomatous Disease, Chronic / microbiology*
Humans
Lung Diseases / chemically induced*
Mycoses / drug therapy*

Substances

Antifungal Agents
Amphotericin B